NCT06940791
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Kyorin University Hospital Tokyo, Japan
Clinical trial condition
Primary Central Nervous System Lymphoma
Explore clinical trials studying Primary Central Nervous System Lymphoma. Study availability and eligibility vary by location and protocol.
38 public trials
17 recruiting studies
Primary Central Nervous System Lymphoma trial results
Recruiting
Rituximab-Methotrexate-Temozolomide-Thiotepa (RMTT) Regimen As First-line Therapy for PCNS DLBCL
NCT06832267
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Zhejiang Cancer Hospital Hangzhou, Zhejiang, China
NCT06830421
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- University Hospital Freiburg, Department Medicine I, Hematology, oncology and stem cell transplantation Freiburg im Breisgau, Baden-Wurttemberg, Germany
- Klinikum Stuttgart, Clinic of Hematology, Oncology and Palliative Care, Stuttgart Cancer Center / Tumor Center Eva Mayr-Stihl Stuttgart, Baden-Wurttemberg, Germany
- University Hospital Aachen Aachen, Germany
- University Hospital Augsburg Augsburg, Germany
NCT04070040
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Sanbo Brain Hospital Capital Medical University Beijing, China
Recruiting
Orelabrutinib,Rituximab and Methotrexate in Newly Diagnosed Primary Central Nervous System Lymphoma
NCT05600660
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- 2nd Affiliated Hospital, School of Medicine, Zhejiang University Hanzhou, Zhejiang, China
Recruiting
Therapeutic Effects of R-IDARAM and Intrathecal Immunochemotherapy on Elderly Patients With PCNSL
NCT02836158
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Navy General Hospital Beijing, Beijing Municipality, China
NCT02657785
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Navy General Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Methotrexate Early Toxicity Monitoring
NCT07406230
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- Assistance Publique - Hôpitaux de Marseille Marseille, France
Not Yet Recruiting
Orelabrutinib Combined With Teniposide, Rituximab and Methotrexate for Newly Diagnosed PCNSL
NCT07185373
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
- West China Hospital of Sichuan University Chengdu, China
- Department of Hematology, Qilu Hospital of Shandong University Jinan, China
Not Yet Recruiting
Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma
NCT05347641
- Conditions
- Primary Central Nervous System Lymphoma
- Locations
-
Not specified